Fruits & Veggies Lower Non-Hodgkin's Risk

Reported today: Eating fruit and vegetables, especially green leaves and broccoli, helps reduce the risk of non-Hodgkin's lymphoma. It's well known that fruit and vegetables can help reduce the risk of cancer. A study from the National Cancer Institute reveals an even more specific link. The researchers looked at the dietary intake of fruit and veg among a group of more than 450 men and women with non-Hodgkin's lymphoma (NHL), comparing them with a group of healthy controls.



Those consuming three or more portions of vegetables a day had a 40 per cent lower risk of NHL compared to those eating less than one serving a day. The link was especially strong for those eating one or more servings a day of green leafy vegetables and one half or more servings a day of vegetables from the broccoli and cabbage family.



Lower risks were also found with higher intakes of whole fruits, yellow, orange or red vegetables, and processed tomato products, such as tomato sauce or juice. And higher intakes of selenium and zinc were linked to lower risk of NHL, although intake of vitamins A, C and E was not. Clearly, eating more fruits and vegetables - especially the green leafy kind, as well as broccoli and cabbage - may go quite some way to reducing the risk of cancer, including NHL.

article



The article didn't keep me from eating fried chicken tonight but may change my mind in the long run :)

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap